HomeVYGR • NASDAQ
add
Voyager Therapeutics Inc
Previous close
$5.43
Day range
$5.41 - $5.72
Year range
$5.19 - $11.72
Market cap
308.39M USD
Avg Volume
650.51K
P/E ratio
9.62
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Sep 2024info | Y/Y change |
---|---|---|
Revenue | 24.63M | 433.79% |
Operating expense | 8.17M | -1.09% |
Net income | -9.04M | 65.08% |
Net profit margin | -36.72 | 93.46% |
Earnings per share | -0.16 | 72.88% |
EBITDA | -12.65M | 55.72% |
Effective tax rate | -0.48% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Sep 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 345.36M | 36.54% |
Total assets | 426.04M | 44.59% |
Total liabilities | 95.73M | -19.17% |
Total equity | 330.31M | — |
Shares outstanding | 54.63M | — |
Price to book | 0.90 | — |
Return on assets | -7.99% | — |
Return on capital | -9.09% | — |
Cash Flow
Net change in cash
(USD) | Sep 2024info | Y/Y change |
---|---|---|
Net income | -9.04M | 65.08% |
Cash from operations | -27.97M | -32.86% |
Cash from investing | 64.35M | 140.65% |
Cash from financing | 14.00K | -95.77% |
Net change in cash | 36.40M | 120.33% |
Free cash flow | -18.00M | -1,555.11% |
About
Founded
2013
Headquarters
Website
Employees
162